EVARF

Lombard Medical, Inc. EVARF

Finances

2016 2015
Revenue 12.169 M -19.49 % 15.114 M
Net income -31.035 M 17.91 % -37.804 M
Income before tax -32.516 M 18.75 % -40.019 M
Income before tax ratio -2.67 -0.91 % -2.65
EBITDA -28.068 M 24.87 % -37.361 M
Net income ratio -2.55 -1.96 % -2.50
Ratio EBITDA -2.31 6.69 % -2.47
Gross profit ratio 0.08 -81.91 % 0.43
Weighted average shs out dil 20.172 M 13.60 % 17.757 M
Weighted average shs out 20.172 M 13.60 % 17.757 M
EPS diluted -1.54 27.70 % -2.13
Earnings per share -1.54 27.70 % -2.13
Gross profit 955.000 K -85.44 % 6.557 M
Income tax expense -1.481 M 33.14 % -2.215 M
Cost of revenue 11.214 M 31.05 % 8.557 M
General and administrative expenses 0.000 0.000
Selling and marketing expenses 0.000 0.000
Other expenses 0.000 0.000
Operating expenses 30.290 M -34.19 % 46.024 M
Cost and expenses 41.504 M -23.96 % 54.581 M
Research and development expenses 7.482 M -32.09 % 11.018 M
Selling general and administrative expenses 22.808 M -34.85 % 35.006 M
Interest income 93.000 K -30.60 % 134.000 K
Interest expense 2.310 M 168.60 % 860.000 K
Depreciation and amortization 2.138 M 18.91 % 1.798 M
Operating income -29.335 M 25.67 % -39.467 M
Operating income ratio -2.41 7.68 % -2.61
Total other income expenses net -805.000 K -10.88 % -726.000 K
2016 2015
2016 2015
Net debt 11.495 M 224.72 % -9.217 M
Total investments 0.000 -100.00 % 176.000 K
Total debt 32.292 M 39.70 % 23.115 M
Accumulated other comprehensive income loss 202.801 M 216.62 % 64.052 M
Retained earnings -257.818 M -13.13 % -227.893 M
Common stock 280.000 K 40.70 % 199.000 K
Total equity 13.973 M -67.59 % 43.115 M
Other non current liabilities 15.697 M 48.08 % 10.600 M
Long term debt 28.025 M 21.24 % 23.115 M
Total non current liabilities 43.722 M 27.14 % 34.389 M
Other current liabilities 2.504 M -41.86 % 4.307 M
Deferred revenue 0.000 0.000
Short term debt 4.267 M 0.000
Total current liabilities 10.072 M 22.29 % 8.236 M
Total liabilities 53.794 M 26.20 % 42.625 M
Other non current assets -14.662 M 8.66 % -16.052 M
Long term investments 0.000 -100.00 % 176.000 K
Intangible assets 32.810 M -13.52 % 37.941 M
GoodWill 14.662 M -8.66 % 16.052 M
Goodwill and intangible assets 47.472 M -12.08 % 53.993 M
Property plant equipment net 1.373 M -54.88 % 3.043 M
Total non current assets 34.183 M -16.95 % 41.160 M
Other current assets 517.000 K 0.000
Short term investments 0.000 0.000
cash and cash equivalents 20.797 M -35.68 % 32.332 M
Cash and short term investments 20.797 M -35.68 % 32.332 M
Total current assets 33.584 M -24.67 % 44.580 M
Inventory 6.877 M 6.42 % 6.462 M
Net receivables 5.393 M -6.79 % 5.786 M
Tax assets 0.000 0.000
Other assets 0.000 0.000
Account payables 3.301 M -15.98 % 3.929 M
Tax payables 0.000 0.000
Deferred revenue non current 0.000 100.00 % 0.000
Minority interest 0.000 0.000
Capital lease obligations 0.000 0.000
Preferred stock 0.000 0.000
Other total stockholders equity 68.710 M 7.61 % 63.853 M
Deferred tax liabilities non current 0.000 -100.00 % 674.000 K
Other liabilities 0.000 0.000
Total assets 67.767 M -20.96 % 85.740 M
2016 2015
2016 2015
Deferred income tax 0.000 0.000
Stock based compensation 0.000 0.000
Change in working capital -3.297 M -90.58 % -1.730 M
Accounts receivables 2.000 K 101.08 % -185.000 K
Inventory -1.481 M 16.75 % -1.779 M
Accounts payables -1.818 M -876.92 % 234.000 K
Other working capital 0.000 0.000
Other non cash items 13.176 M 137.23 % 5.554 M
Net cash provided by operating activities -26.591 M 22.69 % -34.397 M
Investments in property plant and equipment -265.000 K 78.87 % -1.254 M
Acquisitions net 117.000 K 0.000
Purchases of investments 0.000 0.000
Sales maturities of investments 0.000 0.000
Other investing activites 0.000 100.00 % -200.000 K
Net cash used for investing activites -148.000 K 89.82 % -1.454 M
Debt repayment 12.407 M -20.82 % 15.669 M
Common stock issued 5.000 M 0.000
Common stock repurchased 0.000 0.000
Dividends paid 0.000 0.000
Other financing activites -150.000 K 65.75 % -438.000 K
Net cash used provided by financing activities 17.257 M 13.30 % 15.231 M
Effect of forex changes on cash 0.000 0.000
Net change in cash -9.482 M 54.02 % -20.620 M
Cash at beginning of period 30.279 M 0.000
Cash at end of period 20.797 M 200.86 % -20.620 M
Operating cash flow -26.591 M 22.69 % -34.397 M
Capital expenditure -265.000 K 78.87 % -1.254 M
Free CashFlow -26.856 M 24.67 % -35.651 M
2016 2015
Revenue
Net income
Income before tax
Income before tax ratio
EBITDA
Net income ratio
Ratio EBITDA
Gross profit ratio
Weighted average shs out dil
Weighted average shs out
EPS diluted
Earnings per share
Gross profit
Income tax expense
Cost of revenue
General and administrative expenses
Selling and marketing expenses
Other expenses
Operating expenses
Cost and expenses
Research and development expenses
Selling general and administrative expenses
Interest income
Interest expense
Depreciation and amortization
Operating income
Operating income ratio
Total other income expenses net
Net debt
Total investments
Total debt
Accumulated other comprehensive income loss
Retained earnings
Common stock
Total equity
Other non current liabilities
Long term debt
Total non current liabilities
Other current liabilities
Deferred revenue
Short term debt
Total current liabilities
Total liabilities
Other non current assets
Long term investments
Intangible assets
GoodWill
Goodwill and intangible assets
Property plant equipment net
Total non current assets
Other current assets
Short term investments
cash and cash equivalents
Cash and short term investments
Total current assets
Inventory
Net receivables
Tax assets
Other assets
Account payables
Tax payables
Deferred revenue non current
Minority interest
Capital lease obligations
Preferred stock
Other total stockholders equity
Deferred tax liabilities non current
Other liabilities
Total assets
Deferred income tax
Stock based compensation
Change in working capital
Accounts receivables
Inventory
Accounts payables
Other working capital
Other non cash items
Net cash provided by operating activities
Investments in property plant and equipment
Acquisitions net
Purchases of investments
Sales maturities of investments
Other investing activites
Net cash used for investing activites
Debt repayment
Common stock issued
Common stock repurchased
Dividends paid
Other financing activites
Net cash used provided by financing activities
Effect of forex changes on cash
Net change in cash
Cash at beginning of period
Cash at end of period
Operating cash flow
Capital expenditure
Free CashFlow
Date Form 10K
2016
2015